Make a second surgical intervention unnecessary with biodegradable magnesium
A broken bone is always an unpleasant experience. Understandably enough, therefore, after successful bone healing one would be glad to simply forget about surgical procedures and orthopaedic implants once and for all. BRI.Tech enables you to do so by making a second operation unnecessary: the biodegradable implants we develop do not need to be removed later on. The whole secret lies in using elements which are naturally present in the human body and will in due course dissolve without further intervention.
Monday – Friday
9:00 – 18:00
+43(0) 660 5094372
Welcome to BRI.Tech GmbH
BRI.Tech is breaking new ground in orthopaedic and trauma surgery. If you are curious to know how, check out below.
+++ 16.04.2019: Bioretec Ltd. completes an acquisition of BRI.Tech GmbH +++
Tampere, Finland, 16th of April 2019. Bioretec Ltd., a Finnish medical device company focused on development, manufacturing and sales of bioresorbable and bioactive surgical implants for orthopedic and trauma care has completed an acquisition of all outstanding shares of BRI.Tech GmbH located in Graz, Austria.
BRI.Tech has successfully developed and patented a novel biocompatible and bioresorbable metal composition. Products manufactured from this novel composition are currently under testing in first human clinical studies. This novel bioresorbable metal composition has been proven to have superior material properties over the first generation bioresorbable metal compositions during development and pre-clincal steps.
“I am excited to welcome the experienced team of BRI.Tech to join our Bioretec group. This is again one important step in our selected strategy to become the world’s only company having know-how, experience, manufacturing and commercialization capabilities from all of the most innovative fully resorbable materials available in the world. We have a long history of manufacturing and commercilalization our patented self-reinforced biopolymer product platform, we have on-going projects to include also fiber-reinforced biopolymer composites into our product offering and now through this acquisition we will be adding another novel material option, resorbable metals, into our product portfolio”, says Tomi Numminen, Executive Chairman of the Board of Directors of Bioretec.
“Bioretec is recognized as one of the pioneers in the field of resorbable orthopaedic implants. For us this transaction with Bioretec represents an excellent opportunity to continue our efforts in bringing our novel resorbable metal products into the markets. Bioretec has a long and proven history being able to develop, register and commercialize innovative products into the field of orthopaedic products. I am confident that by joining Bioretec group, we will be able to speed up and secure our first product launches and we shall together, in collaboration with our teams, achieve our ambitious targets set“, comments Prof. Dr. Annelie Weinberg, founder and majority shareholder of BRI.Tech.
Within the EU project MgSafe scientists want to improve current imaging technologies to enhance the visibility of magensium implants in the bone during post surgury check ups.
Find more information on: www.mgsafe.eu
+++ BRI.Tech hat es unter fast 300 Teilnehmern in die Top-10 des Gründerwettbewerbs start me up! der Zeitung BILANZ geschafft! +++
Am 07. Juni wurden wir nach Berlin eingeladen und konnten unsere Firma einem großen Publikum präsentieren. Dank dieses Erfolges, berichtet die Zeitung BILANZ in ihrer aktuellen Ausgabe über uns und bei welt.de findet sich ebenfalls ein Artikel!
+++ 7.12. 2017: BRI.Tech was featured in the Kleine Zeitung PRIMUS section – „Steirische Innovation: Streit um magische Schraube“ +++
Our implants are exclusively made of extra-high purified magnesium, which is an essential element in the human body. It is alloyed with zinc and calcium, which are endogenous materials, as well. Nothing else.
AN ENTIRELY NEW TYPE OF IMPLANTS
Our product, BRI.Screw, is designed to provide the mechanical stability required to support a fractured bone despite being singularly light and unobtrusive. This is how we ensure a flawless performance both during and after surgery.
BRI.Tech is supported by experts working in clinical practice in trauma and orthopaedic surgery, as well as by non-clinical researchers specialising in the development of biodegradable metals, and biological and toxicological tests.
Founded after years of academic research, BRI.Tech as a company is closely associated with international programmes and projects researching into biodegradable implants.
MEET OUR TEAM
BRI.Tech was founded by a diverse team with expertise in clinical medicine, medical research, and engineering.
Assoz. Prof. Dr. Annelie-Martina WeinbergCEO and Co-Founder
Annelie is a senior physician at the University Hospital Graz. In 2001, she was the first woman in the trauma surgery department to be awarded the habilitation. Besides that, she has made a name for herself by doing pioneering research in experimental biomechanics, molecular biology, and fracture healing in children, with a focus on absorbable implants. Her lifetime project is the realisation of the Laura Bassi Centre BRIC (Bioresorbable Implants for Children) at the Medical University of Graz: “I had been doing research on absorbable implants for children for several years – without sufficient financial support because the industry did not consider children worth investing in. But now things have changed. BRIC has given me the opportunity to hand down my knowledge to the next generation of researchers, to dedicate myself to scientific innovation.”
Ing. Heinz MoitziCo-Founder and Technical Advisor
Heinz has been working at AT&S (Austria Technologie & Systemtechnik AG) since 1981, initially as head of the mechanics and galvanics department, then as production and plant manager at Hinterberg. As the company’s manager and COO, he spent several years in Shanghai and then returned to the position of Vice President of Production; currently, he holds the position of CTO. His specific managerial responsibilities cover production, research and development, quality control, environment, safety, maintenance, and procurement.
DI Dr. Johannes Andreas EichlerCOO
Johannes was the scientific head of Annelie Weinberg’s research group BRIC and the deputy head of the department of preclinical imaging at the core facility for alternative biomodels and preclinical imaging at the Medical University of Graz before he assumed the responsibility for the operative business of BRI.Tech. Besides the medical studies he pursued from 2012 in the doctoral programme at the Laura Bassi Centre BRIC, Johannes has a master’s degree in telematics from the Graz University of Technology. Johannes is not only experienced in the management of research projects, but also in commercial marketing.
Our product BRI.Screw is the result of eight years of preclinical research, combined with state-of-the-art materials.
BRI.Screw is there to stabilise a fractured bone as long as it is needed in order to support it. Unlike conventional implants made of titanium or stainless steel, its material dissolves naturally and is excreted by the body as soon as the bone is fully functional again.
BRI.Tech is a spin-off company of the research project Laura Bassi Centre BRIC. Due to our close connection to university research, we are involved in various research projects on the development and application of biodegradable implants.
BRI.Tech is constantly developing new designs and shapes for biodegradable implants, which are consequently tested so as to ensure patient safety and mechanical stability. Keep up with our research work!
We will start our clinical first-in-man trials shortly.
BRI.Tech attaches great importance to patient safety – that is why we use highly pure elements the human body is accustomed to and can readily deal with. To rule out the risk of complications, we make sure that the concentrations of magnesium, calcium, and zinc set free during degradation never exceed the recommended level.
Our implants are currently undergoing the certification process according to ISO 13485.
Leave a message to keep in touch
We will let you know as soon as BRI.Screw is commercially available for clinical use.